{"id":49501,"date":"2023-01-02T08:47:00","date_gmt":"2023-01-02T08:47:00","guid":{"rendered":"https:\/\/www.iarc.who.int\/event\/iarc-distinguished-speaker-series-21\/"},"modified":"2023-02-23T09:42:41","modified_gmt":"2023-02-23T09:42:41","slug":"iarc-distinguished-speaker-series-21","status":"publish","type":"event","link":"https:\/\/www.iarc.who.int\/fr\/event\/iarc-distinguished-speaker-series-21\/","title":{"rendered":"IARC Distinguished Speaker Series: Towards building risk-based cancer interception"},"content":{"rendered":"<p>\r\n<style>\r\n    element.style {<br \/>\r\n}<br \/>\r\nh3 {<br \/>\r\n    font-size: 13px !important;<br \/>\r\n    line-height: 16px !important;<br \/>\r\n    text-align: left;<br \/>\r\n}<br \/>\r\n<\/style>\r\n<\/p>\r\n<p>Speaker: <a href=\"https:\/\/www.gustaveroussy.fr\/fr\/suzette-delaloge\" target=\"_blank\" rel=\"noopener noreferrer\">Dr Suzette Delaloge<\/a><br \/>\r\nDirector, Interception Programme<br \/>\r\nDepartment of Cancer Medicine<br \/>\r\nInstitut Gustave Roussy,\u00a0Villejuif, France<br \/>\r\n<br \/>\r\nHost: <a href=\"\/staff_member\/elisabete-weiderpass\/\">DIR<\/a><!-- <a href=\"\/?p=44704\"><strong>WATCH VIDEO<\/strong><\/a>--><\/p>","protected":false},"featured_media":0,"template":"","class_list":["post-49501","event","type-event","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.iarc.who.int\/fr\/wp-json\/wp\/v2\/event\/49501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iarc.who.int\/fr\/wp-json\/wp\/v2\/event"}],"about":[{"href":"https:\/\/www.iarc.who.int\/fr\/wp-json\/wp\/v2\/types\/event"}],"wp:attachment":[{"href":"https:\/\/www.iarc.who.int\/fr\/wp-json\/wp\/v2\/media?parent=49501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}